Three highlights:
1. Dr. Radcliffe is an ophthalmic surgeon at the Microincisional Glaucoma Surgery Center at New York Eye and Ear Infirmary at Mount Sinai in New York City.
2. With the board members’ expertise and leadership, ELT Sight hopes to begin conducting clinical testing of its ExTra ELT laser device in 2020.
3. The company is also eyeing U.S. regulatory approval for the device, which is designed to lower intraocular pressure in glaucoma patients after microinvasive surgery. ExTra ELT has already gained CE mark approval in Europe.
More articles on surgery centers:
50 years of ASCs: 5 things to know
7 critical steps for financial success in your ASC
Delaware medical group opens surgery, wellness center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
